Risperidone (ValiSeek)

利培酮脂质填充胶囊（ValiSeek）

Report date: 2024/06/28 20:00:53

Base Information

Drug NameRisperidone (ValiSeek)
Drug Alias NameVAL-401
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor antagonistsDopamine D2 receptor antagonists
TargetsSerotonin 2a (5-HT2a) receptorDopamine D2 receptor
Therapy Area/IndicationsObsessive-Compulsive DisorderCarcinoma, Non-Small-Cell LungAdenocarcinoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesValiseek Overview
China Registration ClassN/A

Develop Information

Active CompaniesAmbrose Healthcare LtdValiseek Overview
Inactive CompaniesUniversity Of MinhoValiseek Ltd
Active IndicationsCarcinoma, Non-Small-Cell Lung
Inactive IndicationsObsessive-Compulsive DisorderAdenocarcinoma

Other Information

ATC CodeN/A
Related LinksN/A